OM1 Closes $21M in Series B Financing

OM1, a Boston, MA-based health outcomes and technology company, raised $21m in Series B financing.

The round was led by Polaris Partners with participation from existing investors General Catalyst (GC) and 7wire Ventures. In conjunction with the funding, Dave Barrett, Managing Partner at Polaris Partners, joined the OM1 Board of Directors.

The company intends to use the funds to continue the buildout of its intelligent, data-driven solutions.

Founded in 2015 by Dr. Richard Gliklich, OM1 uses standardized health information and artificial intelligence (AI) technology, to gather synthesize, and leverage big clinical data and registries to allow customers to understand, compare and predict health outcomes to personalize patient care.



Join the discussion